Genetic Determinants of Bone Mineral Density and Osteoporosis

Bone mineral density (BMD) and susceptibility to osteoporosis are strongly influenced by genetic variation, with heritability estimates often exceeding 50 per cent. Common and rare sequence variants shape the development, remodelling and structural integrity of cortical and trabecular bone through the regulation of osteoblast and osteoclast activity, extracellular matrix composition and hormonal pathways. Genome-wide association studies (GWAS) have identified hundreds of loci that together explain a substantial fraction of BMD variance, implicating key signalling cascades such as WNT, RANK–RANKL and oestrogen receptor pathways. Functional follow-up in cellular and animal models has confirmed roles for genes affecting osteoblastogenesis, osteoclastogenesis and bone quality parameters that are not captured by density measures alone. Integration of multi-omics data, including chromatin conformation and epigenetic profiling, has refined the mapping from variant to effector gene, revealing tissue- and cell-type-specific mechanisms. The translation of genetic insights into clinical practice holds promise for improved fracture risk prediction, patient stratification and the identification of novel therapeutic targets aimed at enhancing bone strength and preventing fragility fractures on a global scale.

Research from Nature Portfolio

Recent genome-wide analyses of forearm fracture cases have produced a comprehensive atlas of genetic determinants, identifying over forty loci, including novel variants that predominantly influence bone quality rather than density. Functional experiments in mice demonstrated that deletion of specific genes reduces mechanical bone strength, while height and body mass index emerged as causal risk factors for fracture independent of BMD.

An exome-wide study in East Asian women uncovered a variant in the UBAP2 gene that modulates the balance between osteoblast and osteoclast differentiation. Knockdown experiments in mouse and zebrafish models confirmed that reduced UBAP2 expression impairs bone formation and enhances bone resorption, highlighting its key role in bone homeostasis and its potential as a biomarker for osteoporosis.

Site-specific GWAS of skull bone mineral density revealed nearly sixty loci that are enriched in genes governing intramembranous ossification and cranial suture development. Functional validation in zebrafish confirmed that variants in ZIC1 and ATP6V1C1 not only alter cranial bone patterning but also influence local BMD, illustrating pleiotropic effects on skeletal morphology and bone strength.

Genetic Determinants of Bone Mineral Density and Osteoporosis publication trend

The graph below shows the total number of articles in genetic determinants of bone mineral density and osteoporosis across all publications each year (not limited to Nature Index journals).

Technical terms

Genome-wide association study: A population-based analysis that tests for statistical associations between genetic variants across the genome and a trait of interest.

Single nucleotide polymorphism (SNP): A common type of genetic variation involving a single base change in the DNA sequence.

Bone mineral density (BMD): A quantitative measure of mineral content in bone, used as a proxy for bone strength.

Osteoblastogenesis: The process by which precursor cells differentiate into osteoblasts, the bone-forming cells.

Osteoclastogenesis: The differentiation of precursor cells into osteoclasts, the bone-resorbing cells.

Epigenetics: The study of heritable changes in gene expression that do not involve alterations in the DNA sequence, often through chromatin modifications.

References

1. An atlas of genetic determinants of forearm fracture. Nature Genetics (2023).
2. UBAP2 plays a role in bone homeostasis through the regulation of osteoblastogenesis and osteoclastogenesis. Nature Communications (2023).
3. Deciphering the chromatin spatial organization landscapes during BMMSC differentiation. Journal of Genetics and Genomics (2023).
4. Genetic and environmental determinants of bone quality: a cross-sectional analysis of the Hungarian Twin Registry. GeroScience (2024).
5. Genetic Correlation, Shared Loci, and Causal Association Between Sex Hormone‐Binding Globulin and Bone Mineral Density: Insights From a Large‐Scale Genomewide Cross‐Trait Analysis. Journal of Bone and Mineral Research (2023).
6. Bone mineral density loci specific to the skull portray potential pleiotropic effects on craniosynostosis. Communications Biology (2023).
7. Bone Trans-omics: Integrating Omics to Unveil Mechanistic Molecular Networks Regulating Bone Biology and Disease. Current Osteoporosis Reports (2023).
8. Twelve years of GWAS discoveries for osteoporosis and related traits: advances, challenges and applications. Bone Research (2021).